This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.
Although less talked about than bacterial infections, invasive fungal infections are a growing threat that require action.1
In recognition of this, the World Health Organisation (WHO) have recently released a global resource on fungal pathogens, categorising them according to risk to human health. The report provides essential insights to guide surveillance, research, and public health interventions to better control fungal infections and the spread of antifungal resistance.1
Early recognition and diagnosis of invasive fungal infections is crucial for improved outcomes.2,3 Read about current tools and get inspired by real success stories in our key AFS resources.
Antifungal resistance is a real clinical threat that requires shared action.4 Today we have the opportunity to forge a new path for tomorrow.
ABS, antibacterial stewardship; AFS, antifungal stewardship; AMS, antimicrobial stewardship.
Prescribing Information:
Click here for CRESEMBA® (isavuconazole) prescribing information
References:
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024